• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

2000 Biological New Drug Application (NDA) Approvals

This list reflects information regarding the application as of the approval date; it is not updated with regard to applicant or application status changes.


Tradename/
Established Name
Indication for Use Applicant Approval Date
None
Anticoagulant Sodium Citrate 4% w/v Solution, USP
Use only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures Haemonetics Corp
400 Wood Road
Braintree, MA 02184
3/3/2000